SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-21-167842
Filing Date
2021-05-20
Accepted
2021-05-20 16:33:32
Documents
14
Period of Report
2021-05-17
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K d157042d8k.htm   iXBRL 8-K 33633
2 EX-10.1 d157042dex101.htm EX-10.1 10399
6 GRAPHIC g157042g0518084831763.jpg GRAPHIC 2685
  Complete submission text file 0001193125-21-167842.txt   173223

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA ctlt-20210517.xsd EX-101.SCH 3058
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE ctlt-20210517_lab.xml EX-101.LAB 17374
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE ctlt-20210517_pre.xml EX-101.PRE 10945
7 EXTRACTED XBRL INSTANCE DOCUMENT d157042d8k_htm.xml XML 3222
Mailing Address 14 SCHOOLHOUSE ROAD SOMERSET NJ 08873
Business Address 14 SCHOOLHOUSE ROAD SOMERSET NJ 08873 (732) 537-6200
Catalent, Inc. (Filer) CIK: 0001596783 (see all company filings)

IRS No.: 208737688 | State of Incorp.: DE | Fiscal Year End: 0630
Type: 8-K | Act: 34 | File No.: 001-36587 | Film No.: 21944940
SIC: 2834 Pharmaceutical Preparations